Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Metastasis × Topotecan × Clear all

Phase

Phase 1 4 Phase 2 2 Phase 1/2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 20 Small Cell Lung Carcinoma 19 Uterine Cervical Neoplasms 7 Neuroblastoma 6 Fallopian Tube Neoplasms 6 Lung Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Sarcoma 3 Neoplasms 3 Retinoblastoma 2 Malignant mesenchymal tumor 2 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 SCLC 1 Rhabdomyosarcoma 1 Retinal Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia 1 Ganglioneuroblastoma 1 Eye Neoplasms 1 Endometrial Neoplasms 1 Carcinoma 1

Interventions

Leucovorin 20 Fluorouracil 20 Capecitabine 19 Docetaxel 18 Gemcitabine 17 Paclitaxel 16 Radiosurgery 13 Irinotecan 13 Carboplatin 12 Zoledronic Acid 11 Oxaliplatin 11 Cisplatin 11 Radiotherapy 10 Fulvestrant 10 Bevacizumab 10 Drug Therapy 9 pembrolizumab 8 Pemetrexed 8 palbociclib 7 Surgical Procedures, Operative 7 Ibandronic Acid 7 Prednisone 6 130-nm albumin-bound paclitaxel 6 abemaciclib 5 Vinorelbine 5 Letrozole 5 Folfox protocol 5 Floxuridine 5 Doxorubicin 5 Cetuximab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03061812 2021-02-23

TAHOE

AbbVie

Phase 3 Completed

444 enrolled 16 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡